Cargando…
ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
BACKGROUND: Non-alcoholic Fatty Liver Disease (NAFLD), now better known as Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and its progression to Nonalcoholic Steatohepatitis (NASH), more recently referred to as Metabolic (Dysfunction)-Associated Steatohepatitis (MASH) are the most co...
Autores principales: | Convertini, Paolo, Santarsiero, Anna, Todisco, Simona, Gilio, Michele, Palazzo, Donatella, Pappalardo, Ilaria, Iacobazzi, Dominga, Frontuto, Maria, Infantino, Vittoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463545/ https://www.ncbi.nlm.nih.gov/pubmed/37620891 http://dx.doi.org/10.1186/s12967-023-04431-w |
Ejemplares similares
-
PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)
por: Todisco, Simona, et al.
Publicado: (2022) -
New Insights into NF-κB Signaling in Innate Immunity: Focus on Immunometabolic Crosstalks
por: Iacobazzi, Dominga, et al.
Publicado: (2023) -
Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target
por: Infantino, Vittoria, et al.
Publicado: (2021) -
ACLY Nuclear Translocation in Human Macrophages Drives Proinflammatory Gene Expression by NF-κB Acetylation
por: Santarsiero, Anna, et al.
Publicado: (2021) -
TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
por: Todisco, Simona, et al.
Publicado: (2019)